Latest News about vaccine
Recent news which mentions vaccine
Tickers
TC
From TechCrunch
Why The Economic Recovery Likely Won't Come Until 2023
October 23, 2020
From Benzinga
BofA Steps To Sidelines On Sonoco, Looks For Results In 2022
October 23, 2020
Tickers
SON
From Benzinga
From Benzinga
Fintech Focus For October 22, 2020
October 21, 2020
From Benzinga
From Benzinga
Moderna Aims For Emergency Authorization For Coronavirus Vaccine Candidate In December
October 20, 2020
Tickers
MRNA
From Benzinga
From Benzinga
Pfizer CEO: Emergency Use Application For Coronavirus Vaccine Could Come In Late November
October 16, 2020
From Benzinga
BioNTech Analyst Breaks Down Coronavirus Vaccine Readout Timeline
October 14, 2020
From Benzinga
Johnson & Johnson's CFO On COVID-19 Trial Pause: 'We Are Letting The Science Dictate'
October 13, 2020
From Benzinga
Moderna Analyst On Why Coronavirus Vaccine Developer's Stock Is Long-Term Attractive
October 13, 2020
Tickers
MRNA
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
Sell Dollar On Odds Of Biden Win, Coronavirus Vaccine: Goldman Sachs
October 12, 2020
From Benzinga
From Benzinga
From Benzinga
FDA's COVID-19 Vaccine Guidance Shows 'Substantial' Obligations For Developers: Analyst
October 07, 2020
From Benzinga
Health Experts Concerned About China's Coronavirus Vaccine Rush
October 05, 2020
Tickers
SHTDY
From Benzinga
Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19
October 02, 2020
Tickers
JNJ
October FDA, CDC Meetings On Coronavirus Vaccines Set Stage For Emergency Use Authorization
October 01, 2020
From Benzinga
AstraZeneca's COVID-19 Vaccine Trial Delays May Worsen As FDA Widens Investigation
September 30, 2020
From Benzinga
Salesforce creates for profit platform to help governments distribute COVID vaccine when it’s ready
September 30, 2020
From TechCrunch
A Vaccine Is Coming. So What?
September 29, 2020
From ETF Trends
The Next Phase of Our COVID-19 Vaccine Development
September 29, 2020
Tickers
JNJ
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
September 28, 2020
Tickers
JNJ
Moderna Analyst On 4 Coronavirus Vaccine Program Risks
September 24, 2020
From Benzinga
Cramer Reacts To Johnson & Johnson's Coronavirus Vaccine Update: 'Not A Hype Company'
September 23, 2020
Tickers
JNJ
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.